Chemical and Structural Approaches to Rational Drug Design: Handbooks in Pharmacology and Toxicology
Editat de David B. Weiner, William V. Williamsen Limba Engleză Paperback – 30 iun 2020
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 350.94 lei 6-8 săpt. | |
CRC Press – 30 iun 2020 | 350.94 lei 6-8 săpt. | |
Hardback (1) | 2230.57 lei 6-8 săpt. | |
CRC Press – 28 noi 1994 | 2230.57 lei 6-8 săpt. |
Preț: 350.94 lei
Preț vechi: 454.60 lei
-23% Nou
Puncte Express: 526
Preț estimativ în valută:
67.17€ • 70.86$ • 55.97£
67.17€ • 70.86$ • 55.97£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780367449315
ISBN-10: 0367449315
Pagini: 290
Dimensiuni: 178 x 254 mm
Greutate: 0.45 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Handbooks in Pharmacology and Toxicology
Locul publicării:Boca Raton, United States
ISBN-10: 0367449315
Pagini: 290
Dimensiuni: 178 x 254 mm
Greutate: 0.45 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Handbooks in Pharmacology and Toxicology
Locul publicării:Boca Raton, United States
Public țintă
ProfessionalCuprins
Section I: Chemical Approaches to Rational Drug Design 1. Design, Synthesis and Antitumor Activity of an Inhibitor of Ribonucleotide Reductase 2. The Development of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors 3. The Development of Potent Angiotensin II Receptor Antagonists Using a Novel Peptide Pharmacophore Model 4. Endothelin Structure and Development of Receptor Antagonists 5. Molecular Targeting Chemistry in Rational Drug Design Section II: Structural Approaches to Rational Drug Design 6. The Role of X-Ray Crystallography in Structure-Based Rational Drug Design 7. Biocomputational Approaches to Protein-Based Drug Design 8. Architecture and Design of Zinc Protein-Ligand Complexes 9. Design of Immunomodulatory Peptides Based on Active Site Structures
Notă biografică
Weiner, David B. | Williams, William V.
Descriere
This book deals with predominantly synthetic chemical approaches to drug design and explores the use of structure-activity relationships in the design of novel inhibitors of ribonucleotide reductase. It describes the application of the tools of structural biology to pharmaceutical development.